Spectroscopic analysis techniques rely on empirical models that are time consuming and expensive to make. Biopharma companies could speed development and reduce costs using a model-free measuring approach called pure-component analysis, says Nirrin Technologies.
Spectroscopic analysis techniques rely on empirical models that are time consuming and expensive to make.
Biopharma companies could speed development and reduce costs using a model-free measuring approach called pure-component analysis, says Nirrin Technologies.
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Spectroscopic analysis techniques rely on empirical models that are time consuming and expensive to make. Biopharma companies could speed development and reduce costs using a model-free measuring approach called pure-component analysis, says Nirrin Technologies.
Open the app view to save this story, compare related coverage, and continue from the same source.